Dr. Galloway is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
333 Coltman Avenue
Fox Chase Cancer Center
Philadelphia, PA 19111Phone+1 215-728-6900- Is this information wrong?
Education & Training
- University of FloridaResidency, Radiation Oncology, 2006 - 2010
- MedStar Health/Georgetown University HospitalInternship, Internal Medicine, 2005 - 2006
- University of Florida College of MedicineClass of 2005
- University of FloridaB.S., Major: Chemistry; Minors: Business Administration, History, 1997 - 2001
Certifications & Licensure
- PA State Medical License 2010 - 2024
- VA State Medical License 2005 - 2006
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- ARRO Educator of the Year Fox Chase Cancer Center, 2013
- Practical Radiation Oncology Certificate of Excellence in Reviewing 2013
- Join now to see all
Clinical Trials
- Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2009 Nov 01
- TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. Start of enrollment: 2013 Mar 15
- Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Start of enrollment: 2013 Mar 22
- Join now to see all
Publications & Presentations
PubMed
- Imaging and Biomarker Surveillance for Head and Neck Squamous Cell Carcinoma: A Systematic Review and AUC Document.Bain, P., Ward, M., Hu, K., Witek, M., Bakst, R., Chandra, R., Hanna, G., Chang, S., Siddiqui, F., Takiar, V., Shukla, M., Robbins, J., Galloway, T., Margalit, D.> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Dec 31
- Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial.Stuart J Wong, Pedro A Torres-Saavedra, Nabil F Saba, George Shenouda, Jeffrey M Bumpous, Robert E Wallace, Christine H Chung, Adel K El-Naggar, Clement K Gwede, Barba...> ;JAMA Oncology. 2023 Nov 1
- 2 citationsBenefits versus drawbacks of delaying surgery due to additional consultations in older patients with breast cancer.Brian L Egleston, Richard J Bleicher, Carolyn Y Fang, Thomas J Galloway, Slobodan Vucetic> ;Cancer Reports. 2023 May 1
- Join now to see all
Journal Articles
- Impact of Radiographic Findings on Prognosis for Skin Cancer of the Head and Neck with Perineural InvasionTejani M, Galloway TJ, Lango M, Ridge JA, von Mehren M, American Journal of Clinical Oncology, 1/1/2015
- Impact of Radiographic Findings on For Prognosis Skin Cancer With Perineural InvasionBalamucki CJ, DeJesus R, Galloway TJ, Mancuso AA, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM, American Journal of Clinical Oncology-Cancer Clinical Trials, 1/1/2015
- Increasing time to treatment initiation for squamous cell carcinoma of the head and neck: An analysis of the National Cancer DatabaseMurphy CT, Galloway TJ, Handorf EA, Wang L, Mehra R, Flieder D, Ridge JA, Cancer, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- The Survival Impact of Increasing Time to Treatment Initiation for Patients with Head and Neck Cancer in the United States.Murphy CT, Galloway TJ, Handorf EA, Wang L, Mehra R, Flieder D, Ridge JA, ASTRO, San Antonio, TX, 1/1/2015
- Symptom Reduction from IMRT Dose Deintensification: Results from ECOG 1308 Using the Vanderbilt Head and Neck Symptom Survey Version 2 (VHNSS V2).Cmelak A, Li S, Marur S, Zhao W, Westra WH, Chung CH, Gillison ML, Gilbert J, Bauman JE, Wagner LI, Ferris RL, Trevarthen DR, Murphy BA, Galloway T, Burtness B, ASCO, 1/1/2015
- PreTreatment Tumor-Specific Growth Rate as a Temporal Biomarker that Predicts Treatment Failure and Improves Risk Stratification for Oropharyngeal Cancer.Murphy CT, Devarajan K, Wang LS, Mehra R, Ridge JA, Fundakowski C, Galloway TJ, ASTRO, 1/1/2015
- Join now to see all
Lectures
- De-intensification for favorable risk oropharynx cancer – all are created equal?University of Florida, Gainesville, FL - 1/27/2015
- Trying to make sense of an Unknown PrimaryUniversity of Florida, Gainesville, FL - 1/21/2014
- Predictive Value of p16 status on the development of a pathologic complete response (pCR) at planned neck dissection after cisplatin based chemoradiation - a second an...San Francisco, CA - 1/1/2014
- Join now to see all
Other
- Management and prevention of complications of head and neck cancer during initial treatment.Galloway TJ, Amdur RJ; Basow DS (ed), UpToDate
Waltham, MA - 1/1/2015 - Management of late complications of head and neck cancer and its treatment.Galloway TJ, Amdur RJ; Basow DS (ed), UpToDate
Waltham, MA - 1/1/2015
Press Mentions
- Head & Neck Cancer: Your Questions Answered by Fox Chase Cancer CenterApril 13th, 2022
- Many Throat Cancer Patients Can Skip Neck SurgerySeptember 17th, 2014
- Radiation for Head and Neck Cancer May Cause Problems Years LaterOctober 3rd, 2019
Hospital Affiliations
- Fox Chase Cancer CenterPhiladelphia, Pennsylvania
External Links
- Fox Chase Head and Neck Teamhttp://fccc.edu/physicians/care-team/head-neck/index.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: